1105-1114
Review
Anti-angiogenic active immunotherapy: a new approach to cancer treatment
Jianping Pan, Pengfeng Jin, Jie Yan and Dieter Kabelitz
1115-1124
Original Article
The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients
Takuya Osada, Gabriel Chong, Robert Tansik, Timothy Hong and Neil Spector, et al.
1125-1136
Original Article
Different immune correlates associated with tumor progression and regression: implications for prevention and treatment of cancer
Duane H. Hamilton and Peter A. Bretscher
1137-1149
Original Article
Activation of extracellular signaling regulated kinase in natural killer cells and monocytes following IL-2 stimulation in vitro and in patients undergoing IL-2 immunotherapy: analysis via dual parameter flow-cytometric assay
Sri Vidya Kondadasula, Kimberly A. Varker, Gregory B. Lesinski, Don M. Benson and Amy Lehman, et al.
1151-1160
Original Article
CD40 ligation in vivo can induce T cell independent antitumor effects even against immunogenic tumors
Alexander L. Rakhmilevich, Ilia N. Buhtoiarov, Miroslav Malkovsky and Paul M. Sondel
1161-1171
Original Article
Delivery of mengovirus-derived RNA replicons into tumoural liver enhances the anti-tumour efficacy of a peripheral peptide-based vaccine
Jean-Pierre Couty, Anne-Marie Crain, Sylvie Gerbaud, Marilyne Labasque and Carmen Marchiol, et al.
1173-1183
Original Article
Use of radiolabeled monoclonal antibody to enhance vaccine-mediated antitumor effects
Mala Chakraborty, Alexander Gelbard, Jorge A. Carrasquillo, Sarah Yu and Marcelo Mamede, et al.
1185-1195
Original Article
Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1
Junko Matsuzaki, Feng Qian, Immanuel Luescher, Shashikant Lele and Gerd Ritter, et al.
1197-1206
Original Article
TGFβ secreted by B16 melanoma antagonizes cancer gene immunotherapy bystander effect
Claudia Penafuerte and Jacques Galipeau
1207-1214
Original Article
Serum antibodies against Saccharomyces cerevisiae: a new prognostic indicator in metastatic renal-cell carcinoma
Reinhold Ramoner, Andrea Rahm, Hubert Gander, Björn Stollenwerk and Claudia Falkensammer, et al.
1215-1223
Original Article
Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response
Darja Kanduc, Luciana Tessitore, Guglielmo Lucchese, Anthony Kusalik and Emanuel Farber, et al.
1225-1239
Original Article
Preclinical studies in rats and squirrel monkeys for safety evaluation of the bivalent anti-human T cell immunotoxin, A-dmDT390–bisFv(UCHT1)
Jung Hee Woo, Sarah H. Bour, Tony Dang, Yu-Jen Lee and Seong Kyu Park, et al.
1241-1251
Original Article
The anti-tumor agent, ingenol-3-angelate (PEP005), promotes the recruitment of cytotoxic neutrophils by activation of vascular endothelial cells in a PKC-δ dependent manner
Peter Hampson, Dean Kavanagh, Emily Smith, Keqing Wang and Janet M. Lord, et al.
1253-1262
Original Article
The neoplastically transformed (CD30hi) Marek’s disease lymphoma cell phenotype most closely resembles T-regulatory cells
L. A. Shack, J. J. Buza and S. C. Burgess
1263-1270
Short Communication
Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity
Andrew D. Simmons, Marina Moskalenko, Jennifer Creson, Jianmin Fang and Saili Yi, et al.